96744 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links Oxytocins; Vasopressins; Related peptides
V1A Receptor Partial Agonist and Method of Use
#2DESMOPRESSIN ORAL COMPOSITIONS
#3DESMOPRESSIN ORAL COMPOSITIONS
#4Desmopressin oral compositions
#5LABELED OXYTOCIN AND METHOD OF MANUFACTURE AND USE
#6TERLIPRESSIN-OCTADECANEDIOIC ACID CONJUGATE FOR VASOCONSTRICTIVE THERAPY
#7Method of manufacturing a pharmaceutical composition
#8RECOMBINANT PROTEIN COMPRISING MULTIPLE MULTI-PEPTIDE SETS, PHARMACEUTICAL COMPOSITION COMPRISING THE RECOMBINANT PROTEIN, AND METHOD FOR PREPARING THE RECOMBINANT PROTEIN
#9RECOMBINANT PROTEIN COMPRISING MULTIPLE MULTI-PEPTIDE SETS, PHARMACEUTICAL COMPOSITION COMPRISING THE RECOMBINANT PROTEIN, AND METHOD FOR PREPARING THE RECOMBINANT PROTEIN
#10OXYTOCIN ANALOGUES AND METHODS FOR USING THE SAME
#11V1A Receptor Partial Agonist and Method of Use
#12METABOLICALLY STABLE PEPTIDE ANALOGS
#13METHOD FOR INCREASING LONGEVITY AND/OR BUD OPENING OF CUT FLOWERS
#14MANUFACTURE OF DISULFIDE BONDED PEPTIDES
#15Method and formulation for inhalation
#16Method of manufacturing a pharmaceutical composition
#17Labeled oxytocin and method of manufacture and use
#18THERAPEUTICS FOR PRETERM LABOR MANAGEMENT
#19Metabolite inspired selective oxytocin receptor agonists
#20Method of manufacturing a pharmaceutical composition
#21Method for manufacturing oxytocin by liquid-phase polypeptide synthesis
#22METABOLICALLY STABLE PEPTIDE ANALOGS
#23Vasopressin-2 receptor agonists
#24SOLID PHASE PEPTIDE SYNTHESIS
#25METHOD OF MANUFACTURING A PHARMACEUTICAL COMPOSITION
#26Therapeutics for preterm labor management
#27NEW METHODS FOR MAKING BARUSIBAN AND ITS INTERMEDIATES
#28Method of obtaining a binder to prepro-vasopressin or fragments thereof
#29METHOD FOR PREPARATION OF N-ACYL PEPTIDES, POLYPEPTIDES AND PROTEINS
#30FAST DISSOLVING PHARMACEUTICAL COMPOSITION
#31Solid phase peptide synthesis
#32Method and formulation for inhalation
#33PEPTIDES AS OXYTOCIN AGONISTS
#34NOVEL COMPOUND, PRODUCTION METHOD THEREFOR, AND APPLICATION THEREFOR
#35Composition for long-acting peptide analogs
#36Vasopressin-2 receptor agonists
#37Arginine vasopressin pro-hormone as predictive biomarker for diabetes
#38Peptides as oxytocin agonists
#39V1a receptor agonists
#40Fast dissolving pharmaceutical composition
#41METHOD OF OBTAINING A BINDER TO PREPRO-VASOPRESSIN OR FRAGMENTS THEREOF
#42Composition for long-acting peptide analogs
#43Prognosis and risk assessment in stroke patients by determining the level of marker peptides
#44Method for preparing atosiban acetate
#45Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
#46Oxytocin receptor agonists
#47Peptidic vasopressin receptor agonists
#48CHROMATOGRAPHIC PROCESSES AND PURIFIED COMPOUNDS THEREOF
#49IMPROVED PROCESS FOR THE PREPARATION OF DESMOPRESSIN OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS
#50Arginine vasopressin pro-hormone as predictive biomarker for diabetes
#51PROGNOSIS AND RISK ASSESSMENT IN STROKE PATIENTS BY DETERMINING THE LEVEL OF MARKER PEPTIDES
#52Peptidic Constructs with Amino Acid Surrogates
#53Use of peptidic vasopression receptor agonists
#54Composition for long-acting peptide analogs
#55Oxytocin analogues
#56PROCESS FOR PRODUCTION OF CYCLIC PEPTIDES
#57PROCESS FOR PRODUCTION OF CYCLIC PEPTIDES
#58Use of peptidic vasopressin receptor agonists
#59Compounds
#60Composition for long-acting peptide analogs
#61Linear and cyclic melanocortin receptor-specific peptidomimetics
#62Peptidic vasopressin receptor agonists
#63Methods for making intermediates and oxytocin analogues
#64Amino acid surrogates for peptidic constructs
#65Stationary phases and a purification process using the stationary phases
#66Methods for making intermediates and oxytocin analogues
#67Counterion exchange process for peptides
#681-desamino-8-D-arginyl vasopressin analogs
#69Using amines or amino acids as mobile phase modifiers in chromatography